Hou J - Search Results

1

Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity.

Li X, Inks ES, Li X, Hou J, Chou CJ, Zhang J, Jiang Y, Zhang Y, Xu W. Li X, et al. Among authors: hou j. J Med Chem. 2014 Apr 24;57(8):3324-41. doi: 10.1021/jm401877m. Epub 2014 Apr 15. J Med Chem. 2014. PMID: 24694055 Free PMC article.

2

Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activities.

Zhang L, Zhang Y, Chou CJ, Inks ES, Wang X, Li X, Hou J, Xu W. Zhang L, et al. Among authors: hou j. ChemMedChem. 2014 Mar;9(3):638-48. doi: 10.1002/cmdc.201300297. Epub 2013 Nov 12. ChemMedChem. 2014. PMID: 24227760 Free PMC article.

3

Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.

Li X, Hou J, Li X, Jiang Y, Liu X, Mu W, Jin Y, Zhang Y, Xu W. Li X, et al. Among authors: hou j. Eur J Med Chem. 2015 Jan 7;89:628-37. doi: 10.1016/j.ejmech.2014.10.077. Epub 2014 Oct 29. Eur J Med Chem. 2015. PMID: 25462271

4

Synthesis and biological evaluation of novel histone deacetylases inhibitors with nitric oxide releasing activity.

Duan W, Hou J, Chu X, Li X, Zhang J, Li J, Xu W, Zhang Y. Duan W, et al. Among authors: hou j. Bioorg Med Chem. 2015 Aug 1;23(15):4481-4488. doi: 10.1016/j.bmc.2015.06.015. Epub 2015 Jun 20. Bioorg Med Chem. 2015. PMID: 26122774

5

Design, synthesis, and antitumor evaluation of histone deacetylase inhibitors with L-phenylglycine scaffold.

Zhang Y, Li X, Hou J, Huang Y, Xu W. Zhang Y, et al. Among authors: hou j. Drug Des Devel Ther. 2015 Oct 8;9:5553-67. doi: 10.2147/DDDT.S94037. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26504374 Free PMC article.

6

Discovery of Multi-target Anticancer Agents Based on HDAC Inhibitor MS-275 and 5-FU.

Jiang Y, Li X, Li X, Hou J, Ding Y, Zhang J, Xu W, Zhang Y. Jiang Y, et al. Among authors: hou j. Med Chem. 2016;12(1):30-6. doi: 10.2174/1573406411666150714111045. Med Chem. 2016. PMID: 26711240

7

LJNK, an indoline-2,3-dione-based aminopeptidase N inhibitor with promising antitumor potency.

Hou J, Jin K, Li J, Jiang Y, Li X, Wang X, Huang Y, Zhang Y, Xu W. Hou J, et al. Anticancer Drugs. 2016 Jul;27(6):496-507. doi: 10.1097/CAD.0000000000000351. Anticancer Drugs. 2016. PMID: 26872309

8

PXD101 analogs with L-phenylglycine-containing branched cap as histone deacetylase inhibitors.

Li J, Li X, Wang X, Hou J, Zang J, Gao S, Xu W, Zhang Y. Li J, et al. Among authors: hou j. Chem Biol Drug Des. 2016 Oct;88(4):574-84. doi: 10.1111/cbdd.12787. Epub 2016 Jun 24. Chem Biol Drug Des. 2016. PMID: 27235003

9

Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.

Jiang Y, Li X, Hou J, Huang Y, Jia Y, Zou M, Zhang J, Wang X, Xu W, Zhang Y. Jiang Y, et al. Among authors: hou j. Eur J Med Chem. 2016 Oct 4;121:649-657. doi: 10.1016/j.ejmech.2016.05.068. Epub 2016 Jun 1. Eur J Med Chem. 2016. PMID: 27322756

10

Design, synthesis, and preliminary bioactivity evaluation of N¹ -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors.

Wang X, Li X, Li J, Hou J, Qu Y, Yu C, He F, Xu W, Wu J. Wang X, et al. Among authors: hou j. Chem Biol Drug Des. 2017 Jan;89(1):38-46. doi: 10.1111/cbdd.12819. Epub 2016 Oct 26. Chem Biol Drug Des. 2017. PMID: 27416889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,108 results

Search Page

Filters